Acorda Therapeutics (ACOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACOR | AMGN | GILD | VRTX | BIIB |
| Company | Acorda Therapeutics | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7800 | 334.61 | 83.21 | 473.18 | 199.52 |
| High | 0.8500 | 335.13 | 83.44 | 473.18 | 199.96 |
| Low | 0.6116 | 334.30 | 83.15 | 473.18 | 198.00 |
| Last | 0.6610 | 335.49 | 83.08 | 473.14 | 198.07 |
| Change | -0.2187 | -0.46 | -0.82 | -4.76 | -3.37 |
| % Change | -24.86% | -0.14% | -0.98% | -1.00% | -1.67% |
| Volume | 416,900 | 88,774 | 171,026 | 9,609 | 15,746 |
| 20-Day Average Volume | 396,280 | 1,656,529 | 6,406,946 | 931,895 | 789,792 |
| Previous Close | 0.8797 | 335.95 | 83.90 | 477.90 | 201.44 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.1538 | 330.12 | 80.44 | 479.53 | 201.33 |
| 20-Day Raw Stochastic | 0.37% | 80.63% | 81.07% | 31.58% | 39.86% |
| 20-Day Relative Strength | 20.79% | 56.80% | 68.32% | 46.95% | 41.56% |
| Weighted Alpha | -37.54 | +26.66 | +16.86 | +31.70 | -23.45 |
| Today's Opinion | 100% Sell | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Last Month's Opinion | 24% Sell | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -60.65% since 04/04/24 | +0.80% since 09/13/24 | +0.46% since 09/13/24 | -2.51% since 09/13/24 | +1.22% since 09/13/24 |
| Low | 0.6116 on 04/11/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 473.18 on 09/20/24 | 194.75 on 09/16/24 |
| High | 1.6214 on 04/05/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | -94.49% since 03/11/24 | +2.00% since 08/20/24 | +11.29% since 08/20/24 | -2.91% since 08/20/24 | -3.64% since 08/20/24 |
| Low | 0.6116 on 04/11/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 14.1100 on 03/15/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | -95.96% since 01/11/24 | +8.14% since 06/20/24 | +21.46% since 06/20/24 | +0.38% since 06/20/24 | -12.22% since 06/20/24 |
| Low | 0.6116 on 04/11/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 18.0000 on 01/18/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -93.85% since 10/11/23 | +22.73% since 03/20/24 | +12.45% since 03/20/24 | +14.82% since 03/20/24 | -9.23% since 03/20/24 |
| Low | 0.6116 on 04/11/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 18.0000 on 01/18/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 821 | 180,215,344 | 104,527,072 | 123,323,528 | 29,329,060 |
| Shares Outstanding, K | 1,242 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 117,630,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -252,850,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 37,990,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -217,760,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 1.40 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -175.32 on 04/01/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 05/09/24 | 10/29/24 | 11/05/24 | 11/04/24 | 11/13/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 17.85 | 0.00 | 12.15 |